Table 2 Clinical chemistry (mean ± SD).
1-month follow-up | 6-month follow-up | |||||||
|---|---|---|---|---|---|---|---|---|
Group | AAV2-VEGF-B186 (n = 7) | AAV2-GFP/LacZ (n = 7) | AAV2-VEGF-B186 (n = 3) | AAV2-GFP/LacZ (n = 4) | ||||
Time point | Pre-GT | 1 Month | Pre-GT | 1 Month | Pre-GT | 1 Month | Pre-GT | 1 Month |
TnI (ng/mL) | 0.50 ± 0.08 | 0.16 ± 0.09 | 0.52 ± 0.10 | 0.08 ± 0.03 | 0.35 ± 0.09 | 0.34 ± 0.16 | 3.56 ± 3.01 | 0.13 ± 0.04 |
ALAT (U/L) | 79 ± 4 | 58 ± 5 | 75 ± 6 | 65 ± 8 | 72 ± 8 | 74 ± 7 | 83 ± 10 | 73 ± 5 |
AFOS (U/L) | 148 ± 10 | 153 ± 19 | 168 ± 22 | 181 ± 21 | 157 ± 22 | 110 ± 10 | 157 ± 13 | 103 ± 10 |
CRP (mg/L) | 46 ± 10 | 36 ± 10 | 52 ± 21 | 42 ± 5 | 37 ± 9 | 27 ± 8 | 30 ± 14 | 19 ± 8 |
Creatinine (µmol/L) | 103 ± 5 | 118 ± 7 | 106 ± 4 | 124 ± 7 | 110 ± 7 | 165 ± 7 | 92 ± 3 | 167 ± 3 |